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The Nurses’ Health Study, a cohort of 121 701 female registered nurses,
was established in 1976 to prospectively address the relationship between
the use of oral contraceptives and the risk of breast cancer. Through followup questionnaires every 2 years, exposures have been updated and new
exposure assessments added. Repeated measures have allowed a broad
range of analyses, including change measures and risk according to time
since exposure. Responding to emerging public health issues and accessing
new measures (such as exposure to silicone implants, air pollution and
the built environment) has allowed investigators to address an evolving
spectrum of topics. Prospective data on a wide range of chronic conditions
have allowed assessment of preventable fractions of diseases, development
of risk prediction models, and other applications that bring data to bear on
translation of epidemiologic findings to health policy and practice. The aim
of this report is to highlight the features of the Nurses’ Health Study and
other cohorts that demonstrate continuing contributions to the changing
epidemiology of chronic conditions.

Key points
• Historically, many cohorts depend on a
single baseline questionnaire to assess
exposures. By continuing to contact
participants and update exposure
measures, the Nurses’ Health Study has
allowed the addition of new exposures
that address emerging public health
issues. This has set the standard for more
contemporary cohort studies
• Repeated measures allowed the study of
change and time from exposure in relation
to the changing risk of disease or benefits
of prevention
• Documenting incident cases of many
diseases, beyond the original focus on
cancer, gives richer insights into women’s
health and wellbeing as they age,
demonstrating the risks and benefits of
potential prevention interventions

Introduction
The Nurses’ Health Study began in the US in 1976 and continues 40 years
later. This paper summarises a few examples of how the cohort has adapted
to changing public health issues and how it continues to contribute across a
broad range of health conditions.
We have previously addressed the use of data from cohort studies such as
the Nurses’ Health Study to address the overall impact of the National Cancer
Institute–funded research program in cancer epidemiology.1 In particular, we
focused on the phases of the discovery, development and delivery paradigm
of cancer research. Evidence from prospective cohort studies can help to
explain the aetiology of disease with fewer sources of bias than retrospective
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studies. However, tracing research reports to their use
as part of the scientific evidence base – to inform social
strategies to reduce the burden of disease and improve
population health – is less well developed. Using this
approach, we showed that the evidence from the study
has contributed to the International Agency for Research
on Cancer reports on alcohol and cancer, exogenous
hormones and breast cancer, and to numerous reports
of the US Surgeon General.1 These outcomes may be
expected of a well-conducted cohort study contributing to
the establishment of causality.
The Nurses’ Health Study cohort was established in
1976 to evaluate risks to women’s health, including the
relationships between oral contraceptives and breast
cancer risk; exogenous hormone therapy and breast
cancer risk; and smoking, hair dyes and cancer risk.
However, the cohort has evolved to address a broad
range of lifestyle factors, such as exposure to silicone
implants, air pollution and the built environment.2 The
addition of biological samples allowed the research to
expand to study biomarkers of exposure to, for example,

diet, hormones and trace elements2 (see Figure 1). The
study also expanded from an original focus on cancer to
include cardiovascular disease (CVD), type 2 diabetes,
fractures, rheumatologic conditions and other outcomes
of interest in women’s health. This expansion required
funders to accept a core role for the National Cancer
Institute and secondary roles for other funding bodies.

Responding to public health
issues
The development of the Nurses’ Health Study included
responding to public health issues. Additional important
questions that were brought to the cohort included
whether silicone breast implants increased the risk
of connective tissue diseases. Dr Matthew Liang, a
rheumatologist and colleague at Harvard Medical School,
after attending a Food and Drug Administration hearing
about implants, asked the investigators if the Nurses’
Health Study might address the issue prospectively.

Figure 1. Evolution of the Nurses’ Health Study
2000
Cheek cells collected from 35 000 participants

1999
Second blood and first urine collection

1997
Adolescent diet assessed among participants in NHS II

1996
Growing Up Today Study – 16 000 children (10–14) of women
in NHS II recruited to study of diet activity and weight gain

1994
Mothers of NHS participants study began

1992
SF-36, Berkman–Syme Social Network Index added to follow-up

1989
Collected blood samples from 33 000 participants
NHS II began

1988
Funding for collection of weight history
to relate to health outcomes

1987
Funding for pilot development of blood collection
Funding for a study on benign breast disease and
risk of breast cancer in the NHS cohort

1984
FFQ expanded

1983
Toenails collected from 63 000 participants

1982
Optical scanning of questionnaires
implemented for increased efficiency

1980
FFQ included in follow-up mailing to cohort

1978
Developed FFQ
Funding for follow-up of cohort

1976
Initial questionnaire mailed to NHS participants

FFQ = food frequency questionnaire; NHS = Nurses’ Health Study; SF-36 = 36-Item Short Form Health Survey
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Dr Liang had already collaborated on confirmation
of rheumatologic conditions within the cohort. By
1992, 109 750 women were still participating in the
study. Among many other topics in the 1992 biennial
questionnaire, we asked participants if they had ever had
breast implant surgery, or silicone, paraffin or collagen
injections. Of the 89 376 women (81.4%) who returned
the questionnaire, 88 153 answered the questions about
breast implants and injections. We sent a supplementary
questionnaire to obtain details about type of implant
and indications to the 1861 women who reported having
breast implants, or any sort or silicone, paraffin or
collagen injections. Overall, we observed no association
between implants and incidence of connective
tissue diseases.3
Other exposures that are not readily assessed through
intervention studies and, hence, require observational
designs include rotating shift work. The Nurses’ Health
Study represented a unique resource – a cohort of nurses
who had a personal history of shift work. Participants had
all been trained as registered nurses before enrolment
and many continued to participate in the workforce. In
1988, we assessed the total number of years participants
had worked rotating shift work. We showed a significant
relationship between more years of rotating night shift
work and risk of coronary heart disease (6 or more years
of shift work vs never worked shift work: RR 1.51; 95% CI
1.12, 2.03)4, increased risk of breast cancer with a trend
of increasing risk with increasing years of rotating night
shifts (30 or more years of shift work vs never worked shift
work: RR 1.36; CI 1.04, 1.78)5, and an equal increase in
the risk for colorectal cancer.6

7–9% lower risk of CVD during the subsequent 4 years,
and those whose diet quality worsened had a significantly
increased risk of CVD.8 Diet validation data comparing
food frequency questionnaires with diet records also
allowed for development of methods to adjust for
measurement error.
Studies also distinguish time-course relationships
between dietary exposures and outcomes, perhaps
most fruitfully for colorectal cancer. By addressing the
time from diet assessment of folate intake and risk of
colorectal cancer, Lee et al.9 showed that a reduction in
colorectal cancer was most evident 12–16 years after diet
assessment, and that protection was reduced the shorter
the follow-up from diet assessment. This confirmed
that folate is operating earlier rather than later in the
development of colorectal carcinogenesis.

Risk models
In the 1980s, using the data from the Nurses’ Health
Study cohort, I was challenged by Dr Chris Bain to take
the Pike model of breast cancer incidence10 – which
states that breast tissue ageing begins at menarche,
decreases after first birth and decreases further after
menopause, and allows for an adverse effect of first
pregnancy – and attempt to validate this model in the
prospective cohort. We developed a lifecourse model
of incidence, with risk accumulating at different rates
corresponding to intervals defined by reproductive
variables, menarche, age and spacing of births, and
menopause, and according to weight and height across
life. The 20 years of research has provided insights to
the aetiology of breast cancer, allowed for the refined
analysis of the interval from menarche to first full-term
pregnancy (documenting the previous reports from casecontrol studies that closer spacing of births, and not just
the total number of pregnancies, lowers the risk) and
helped to expand the field of risk prediction in cancer.11
We noted that risk of benign breast disease accumulated
particularly before menarche12, although we have not yet
determined what lifestyle or environmental exposures
are responsible for, or modify, this risk pathway to breast
cancer. Expanding from the work of Armitage and Doll13,
we also applied a lifecourse approach through logincidence modelling to ovarian cancer, melanoma and
colorectal cancer risk prediction.

Repeated measures
One important feature of the cohort follow-up has been
the repeated assessment of exposure over time to,
for example, weight fluctuations, tobacco smoke and
diet. The cohort has enabled detailed assessment of
the impact of weight change across the lifecourse –
partitioning weight change from age 18 to current age
(if premenopausal) or to menopause, and then change
after menopause among postmenopausal women.
We showed that weight loss after menopause was
associated with a reduction in the risk of breast cancer.
There was also a clear relationship between smoking
cessation (and remaining a nonsmoker) and change
in total mortality by time since quitting7, and data are
not confounded by smoking recidivism (a factor that
substantially underestimates the benefits of quitting in
cohorts that do not update exposure status for smoking
during follow-up). Changes in dietary patterns and
nutrients over time allowed us to evaluate the changes
in risk of CVD compared with those who did not change
their diet quality. Compared with women who did not
increase the quality of their diet, those who had the
largest improvements in diet quality over 4 years had

Expanding the scope
In this section, I demonstrate the changing face of
epidemiologic research during the past 40 years, and
the adaptability required by researchers and funders to
continue to address timely public health issues. Among
the early changes in the conduct of epidemiological
studies – and often followed by others – is the use of
pathology samples to refine the understanding of disease
aetiology.14 This first applied to benign breast lesions, but
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after collection of tissue blocks from incident cases of
invasive breast cancer and colon cancer, we applied a
range of biomarker studies to better understand pathways
and mechanisms from lifestyle to cancer aetiology and
outcomes.15,16 This latter evaluation showed that a history
of breastfeeding was inversely related to basal-like breast
cancer.16 The cohort has also been a rich source of
evidence on adiposity in childhood and its relationship
to subsequent risk of breast cancer, where it is inversely
related to oestrogen receptor–negative breast cancer.17
Studies of survivorship after cancer diagnosis and
treatment were also an early addition to the ongoing
cohort study. In part, this reflected the growing number
of survivors in the population and a search for guidance
on lifestyle after cancer. In 1992, we added measures of
quality of life to the cohort follow-up questionnaire and
then followed participants with repeated measures every
4 years, enabling the quantification of change in quality
of life after diagnosis of breast cancer, with the potential
to control for prediagnostic values.18 Subsequent studies
addressed physical activity and diet changes after
cancer diagnosis, showing that higher levels of physical
activity reduced risk of recurrence and death among
women with breast and colorectal cancer.19
Study participants live across the US, and this
afforded opportunities to study the relationship between
air pollution and health outcomes, while controlling for
established causes such as smoking and blood pressure
when assessing the incidence of CVD.20 In addition, we
added measures of neighbourhood walkability to the
underlying cohort data on individually assessed lifestyle
measures. With these data, investigators have also
assessed exposure to particulate air pollution, and the
relationship between built environment, physical activity
and body mass index. Air pollution and incidence of a
broad range of chronic conditions were studied once
the residential history and air quality data were linked
and updated.
Another broad application of the cohort has been
to determine the preventable burden of disease across
multiple outcomes, from heart disease to diabetes and
cancers. This again reflects both the power of the cohort
and the richness achieved through detailed investigation
of aetiology of many chronic conditions in women across
middle and older ages. The wealth of data attest to the
exogenous factors driving incidence of these chronic
conditions in Western society.21

and air pollution – that are now more readily available
to investigators allows for timely focus on multilevel
drivers of public health outcomes. The breadth of health
conditions being documented and studied all add to
the value of the Nurses’ Health Study as a model of a
cohort study impacting public health policy and practice.
Some findings translate to changes in regulation, such
as transfat and its effect on heart disease and diabetes;
others support prevention guidelines, such as aspirin and
reduction in risk of colorectal cancer; and others guide
recommendations by the US Surgeon General, such as
on the adverse health effects of smoking.
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